CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, San Francisco |
Dr. Ophir Klein MD, PhD |
New Faculty II |
Laying the groundwork for building a tooth: analysis of dental epithelial stem cells |
$3,075,251 |
University of California, Merced |
Dr. Kara E McCloskey |
New Faculty II |
Building Cardiac Tissue from Stem Cells and Natural Matrices |
$1,656,083 |
University of California, Irvine |
Dr Edwin S Monuki |
New Faculty II |
Mechanisms in Choroid Plexus Epithelial Development |
$2,793,395 |
University of California, Berkeley |
Dr. Lin He |
New Faculty II |
The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells |
$1,406,823 |
University of California, San Francisco |
Dr. Robert Blelloch Dr. |
New Faculty II |
Mechanisms of small RNA regulation in early embryonic development |
$2,790,695 |
University of California, Los Angeles |
Dr. Antoni Ribas MD/PhD |
New Faculty II |
Stem Cells for Immune System Regeneration to Fight Cancer |
$3,072,000 |
San Diego State University Foundation |
Dr. Ricardo M. Zayas |
New Faculty II |
The molecular basis underlying adult neurogenesis during regeneration and tissue renewal |
$1,712,225 |
University of Southern California |
Dr. Qilong Ying |
New Faculty II |
Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation |
$2,261,174 |
University of California, San Diego |
Dr. Benjamin D. Yu |
New Faculty II |
Regulation of Adult Stem Cell Proliferation by RAS and Cell-Permeable Proteins |
$3,017,978 |
University of California, San Diego |
Dr. Shyni Varghese |
New Faculty II |
A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment |
$2,300,569 |
University of California, San Francisco |
Dr. Holger F Willenbring |
New Faculty II |
Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells |
$2,832,008 |
Children’s Hospital of Los Angeles |
Dr. Tracy Cannon Grikscheit M.D. |
New Faculty II |
Mechanism of Tissue Engineered Small Intestine Formation |
$3,211,122 |
University of California, San Diego |
Dr. Mana M Parast |
New Faculty II |
Molecular Mechanisms of Trophoblast Stem Cell Specification and Self-Renewal |
$3,077,918 |
University of Southern California |
Dr. Gage Crump |
New Faculty II |
Skeletogenic Neural Crest Cells in Embryonic Development and Adult Regeneration of the Jaw |
$2,247,403 |
University of California, San Diego |
Catriona Jamieson |
New Faculty II |
Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells |
$3,065,572 |
Stanford University |
Dr. Ching-Pin Chang |
New Faculty II |
VEGF signaling in adventitial stem cells in vascular physiology and disease |
$3,005,695 |
Ludwig Institute for Cancer Research |
Dr. Bing Ren |
New Faculty II |
Mechanisms of chromatin dynamics at enhancers during ES cell differentiation |
$1,726,564 |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
New Faculty II |
Stem Cells in Lung Cancer |
$2,381,572 |
University of California, Davis |
Dr. Paul S. Knoepfler |
New Faculty II |
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency |
$2,157,255 |
University of California, San Francisco |
Dr. Jeremy Reiter |
New Faculty II |
High throughput modeling of human neurodegenerative diseases in embryonic stem cells |
$2,259,092 |
Gladstone Institutes, J. David |
Dr. Benoit Bruneau |
New Faculty II |
Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors |
$2,723,653 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Zhuohua Zhang |
New Cell Lines |
Derivation of Parkinson’s Disease Coded-Stem Cells (PD-SCs) |
$1,556,448 |
University of California, Los Angeles |
Dr. Jerome A. Zack Ph.D. |
New Cell Lines |
Generation of clinical grade human iPS cells |
$1,341,000 |
Stanford University |
Dr. Renee Reijo Pera PhD |
New Cell Lines |
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype |
$1,409,243 |
University of Southern California |
Dr. Martin Pera |
New Cell Lines |
New Technology for the Derivation of Human Pluripotent Stem Cell Lines for Clinical Use |
$1,266,134 |
Stanford University |
Michael T. Longaker M.D. |
New Cell Lines |
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts |
$1,406,636 |
Stanford University |
Dr. Julie Baker |
New Cell Lines |
Derivation of hESC Lines with Disease Lesions |
$1,404,725 |
Scripps Research Institute |
Dr. Sheng Ding Dr. |
New Cell Lines |
Derivation of New ICM-stage hESCs |
$936,973 |
Gladstone Institutes, J. David |
Sheng Ding PhD |
New Cell Lines |
Derivation of New ICM-stage hESCs |
$778,859 |
Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
New Cell Lines |
Induced Pluripotent Stem Cells for Cardiovascular Diagnostics |
$1,708,560 |
Stanford University |
Dr. Michele Calos |
New Cell Lines |
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses |
$1,406,875 |
University of California, San Francisco |
Dr. Susan J Fisher PhD |
New Cell Lines |
Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines |
$1,383,419 |
University of California, San Francisco |
Dr. Miguel Ramalho-Santos |
New Cell Lines |
Somatic cell age and memory in the generation of iPS cells |
$1,307,201 |
University of California, San Francisco |
Dr. Long-cheng Li |
New Cell Lines |
Induction of pluripotent stem cells by small RNA-guided transcriptional activation |
$1,368,461 |
Gladstone Institutes, J. David |
Robert V Farese |
New Cell Lines |
Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations |
$1,696,424 |
Salk Institute for Biological Studies |
Dr. Fred H Gage |
New Cell Lines |
Development of Induced Pluripotent Stem Cells for Modeling Human Disease |
$1,737,720 |
University of California, Los Angeles |
Dr. Amander Clark Dr. |
New Cell Lines |
Generation of Pluripotent Cell Lines from Human Embryos |
$1,167,416 |
University of California, Irvine |
Dr. Leslie M Thompson |
New Cell Lines |
New Cell Lines for Huntington’s Disease |
$1,302,526 |
University of California, San Diego |
Dr. Steven F Dowdy |
New Cell Lines |
Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin. |
$1,073,585 |
University of California, Davis |
Dr. Mark Zern |
Comprehensive Grant |
An in vitro and in vivo comparison among three different human hepatic stem cell populations. |
$2,251,223 |
Stanford University |
Professor Irving L Weissman MD |
Comprehensive Grant |
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells |
$2,471,386 |
University of California, San Francisco |
Dr. Andrew D. Leavitt MD |
Comprehensive Grant |
Understanding hESC-based Hematopoiesis for Therapeutic Benefit |
$2,460,822 |
University of California, Irvine |
Dr Hans S Keirstead |
Comprehensive Grant |
hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury |
$2,158,445 |
University of California, Los Angeles |
Dr. Jerome A. Zack Ph.D. |
Comprehensive Grant |
Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease |
$2,401,903 |
University of California, San Diego |
Dr. Yang Xu |
Comprehensive Grant |
Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells |
$2,467,200 |
University of California, Davis |
Dr. Alice F Tarantal |
Comprehensive Grant |
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells |
$2,166,757 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Stuart A Lipton |
Comprehensive Grant |
MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells |
$2,832,000 |
Stanford University |
Dr. Stefan Heller |
Comprehensive Grant |
Generation of inner ear sensory cells from human ES cells toward a cure for deafness |
$2,330,371 |
University of California, Irvine |
Dr. Peter John Donovan |
Comprehensive Grant |
Improved hES Cell Growth and Differentiation |
$2,381,713 |
Children’s Hospital of Los Angeles |
Dr. Gay M. Crooks |
Comprehensive Grant |
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) |
$575,994 |